异常的上腺素清除和上腺素受体敏感性在异常性静态不耐受症
G Jacob1, J R Shannon, F Costa
1Nathan Blaser Shy-Drager Research Program, Autonomic Dysfunction Center, Departments of Medicine, Pharmacology, and Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Circulation
|April 6, 1999
概括
慢性静止不耐症 (OI) 患者表现出交感神经系统功能受损. 他们的身体调节得很差,对刺激有异常的反应,表明心血管控制有障碍.
科学领域:
- 心血管生理学心血管生理学
- 自主神经系统功能 自主神经系统功能
- 神经科学是一个神经科学.
背景情况:
- 慢性静止不耐症 (OI) 涉及到站立时大脑血流不足的症状.
- 典型的OI以显著的心率增加 (>30bpm) 而没有显著的血压下降为标志.
- 潜在的原因包括血液体积低,部分自主功能障碍或超上腺状态.
研究的目的:
- 研究OI患者控制心血管反应的自主神经元中的功能异常.
- 测试慢性OI中同情心血管调节失调的假设.
主要方法:
- 通过自主功能测试对13名OI患者和10名对照进行了比较.
- 测量了系统性上腺素 (NE) 动力学 (溢出,清除) 卧底和站立.
- 评估了对提拉胺,上腺激素激动剂 (异二醇,乙烯) 的反应,巴罗反射灵敏度和内在心率的反应.
主要成果:
- 与对照组相比,OI患者在站立时表现出降低的NE清除.
- 与对照组不同,提拉胺的使用并没有显著增加OI患者的NE溢出.
- 在OI患者中,对异二醇和烯酸的敏感性增加,巴罗反射敏感性降低.
结论:
- 慢性OI患者表现出显著失调的同情心血管调节.
- 关键发现包括受损的NE清除,对提拉胺的反应减弱,对上腺激素激动剂的敏感性增加.
相关概念视频
Cross-reactivity
Overview
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...


